mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.2 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.2 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |